• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与启动子甲基化相关的FAM107A失活通过FAK/PI3K/AKT途径影响前列腺癌进展。

FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway.

作者信息

Ke Shuai, Liu Zelin, Wang Qinghua, Zhai Guanzhong, Shao Haoren, Yu Xi, Guo Jia

机构信息

Department of Urology, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuhan 430060, China.

出版信息

Cancers (Basel). 2022 Aug 13;14(16):3915. doi: 10.3390/cancers14163915.

DOI:10.3390/cancers14163915
PMID:36010909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9405870/
Abstract

Prostate cancer (PCa) is one of the most common cancers and is the second leading cause of mortality in men. Studies exploring novel therapeutic methods are urgently needed. FAM107A, a coding gene located in the short arm of chromosome3, is generally downregulated in PCa and is associated with a poor prognosis. However, the downregulation of FAM107A in PCa and the mechanism of its action remain challenging to determine. This investigation found that downregulation of FAM107A expression in PCa was caused by hypermethylation of CpG islands. Furthermore, DNA methyltransferase 1 (DNMT1) was involved in maintaining hypermethylation. Mechanistically, overexpression of FAM107A inhibits tumor cell proliferation, migration, invasion and promotes apoptosis through the FAK/PI3K/AKT signaling pathway, indicating that FAM107A may be a molecular brake of FAK/PI3K/AKT signaling, thus limiting the active state of the FAK/PI3K/AKT pathway. These findings will contribute to a better understanding of the effect of FAM107A in PCa, and FAM107A may represent a new therapeutic target for PCa.

摘要

前列腺癌(PCa)是最常见的癌症之一,是男性第二大死亡原因。迫切需要探索新治疗方法的研究。FAM107A是位于3号染色体短臂上的一个编码基因,在前列腺癌中通常表达下调,且与预后不良有关。然而,FAM107A在前列腺癌中的下调及其作用机制仍难以确定。本研究发现,前列腺癌中FAM107A表达下调是由CpG岛的高甲基化引起的。此外,DNA甲基转移酶1(DNMT1)参与维持高甲基化。从机制上讲,FAM107A的过表达通过FAK/PI3K/AKT信号通路抑制肿瘤细胞增殖、迁移、侵袭并促进凋亡,表明FAM107A可能是FAK/PI3K/AKT信号的分子制动器,从而限制FAK/PI3K/AKT通路的激活状态。这些发现将有助于更好地理解FAM107A在前列腺癌中的作用,并且FAM107A可能代表前列腺癌的一个新治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/5f127127bd85/cancers-14-03915-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/3e6c6717eb0e/cancers-14-03915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/630892c60535/cancers-14-03915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/2fc86ee51239/cancers-14-03915-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/8d39ca27729f/cancers-14-03915-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/06872b1fd269/cancers-14-03915-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/97abba441cfa/cancers-14-03915-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/394b0bcebadf/cancers-14-03915-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/0a86dab56a15/cancers-14-03915-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/68971b35cb00/cancers-14-03915-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/5f127127bd85/cancers-14-03915-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/3e6c6717eb0e/cancers-14-03915-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/630892c60535/cancers-14-03915-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/2fc86ee51239/cancers-14-03915-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/8d39ca27729f/cancers-14-03915-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/06872b1fd269/cancers-14-03915-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/97abba441cfa/cancers-14-03915-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/394b0bcebadf/cancers-14-03915-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/0a86dab56a15/cancers-14-03915-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/68971b35cb00/cancers-14-03915-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf60/9405870/5f127127bd85/cancers-14-03915-g010.jpg

相似文献

1
FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway.与启动子甲基化相关的FAM107A失活通过FAK/PI3K/AKT途径影响前列腺癌进展。
Cancers (Basel). 2022 Aug 13;14(16):3915. doi: 10.3390/cancers14163915.
2
Overexpression of GATA5 Inhibits Prostate Cancer Progression by Regulating PLAGL2 via the FAK/PI3K/AKT Pathway.GATA5的过表达通过FAK/PI3K/AKT途径调控PLAGL2来抑制前列腺癌进展。
Cancers (Basel). 2022 Apr 21;14(9):2074. doi: 10.3390/cancers14092074.
3
Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway.跨膜蛋白100通过FAK/PI3K/AKT途径调控SCNN1D对前列腺癌进展的影响。
Transl Oncol. 2023 Jan;27:101578. doi: 10.1016/j.tranon.2022.101578. Epub 2022 Nov 11.
4
Identification of the Putative Tumor Suppressor Characteristics of FAM107A Pan-Cancer Analysis.FAM107A的假定肿瘤抑制特征鉴定 泛癌分析
Front Oncol. 2022 May 20;12:861281. doi: 10.3389/fonc.2022.861281. eCollection 2022.
5
Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1 that Promotes the Progression of Prostate Cancer.由DNMT1介导的DNA高甲基化导致CAMK2N1下调,促进前列腺癌进展。
J Oncol. 2023 Jan 30;2023:4539045. doi: 10.1155/2023/4539045. eCollection 2023.
6
GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.GOLM1通过激活PI3K-AKT-mTOR信号通路促进前列腺癌进展。
Prostate. 2018 Feb;78(3):166-177. doi: 10.1002/pros.23461. Epub 2017 Nov 27.
7
CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.CMTM5 通过 EGFR/PI3K/AKT 信号通路抑制前列腺癌的发展。
Mol Med Rep. 2022 Jan;25(1). doi: 10.3892/mmr.2021.12533. Epub 2021 Nov 18.
8
Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.长链非编码 RNA ZEB1-AS1 下调通过 miR-342-3p/CUL4B 轴调控 PI3K/AKT/mTOR 信号通路抑制前列腺癌细胞增殖、迁移和侵袭。
Cancer Biother Radiopharm. 2020 Nov;35(9):661-672. doi: 10.1089/cbr.2019.3123. Epub 2020 Apr 9.
9
Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer.通过抑制前列腺癌中的PI3K/AKT信号通路抑制肿瘤进展。
Front Cell Dev Biol. 2021 Jun 25;9:678967. doi: 10.3389/fcell.2021.678967. eCollection 2021.
10
14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.14, 15-EET 通过上调整合素 αvβ3 并激活 FAK/PI3K/AKT 信号通路诱导乳腺癌细胞 EMT 和顺铂耐药。
J Exp Clin Cancer Res. 2018 Feb 9;37(1):23. doi: 10.1186/s13046-018-0694-6.

引用本文的文献

1
Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy.BK002中的植物化学协同作用:靶向前列腺癌治疗的先进分子对接见解
Front Pharmacol. 2025 Feb 17;16:1504618. doi: 10.3389/fphar.2025.1504618. eCollection 2025.
2
promotes tumor progression via the Integrin α2/β1-PI3K-AKT-mTOR-C-myc signaling pathway in colorectal cancer.通过整合素α2/β1 - PI3K - AKT - mTOR - C - myc信号通路促进结直肠癌的肿瘤进展。
Int J Biol Sci. 2025 Jan 27;21(4):1497-1512. doi: 10.7150/ijbs.102742. eCollection 2025.
3
SULF1 regulates malignant progression of colorectal cancer by modulating ARSH via FAK/PI3K/AKT/mTOR signaling.

本文引用的文献

1
Overexpression of GATA5 Inhibits Prostate Cancer Progression by Regulating PLAGL2 via the FAK/PI3K/AKT Pathway.GATA5的过表达通过FAK/PI3K/AKT途径调控PLAGL2来抑制前列腺癌进展。
Cancers (Basel). 2022 Apr 21;14(9):2074. doi: 10.3390/cancers14092074.
2
FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion.FAM107A作为膀胱癌中的一种肿瘤抑制因子,可抑制细胞增殖、迁移和侵袭。
Ann Clin Lab Sci. 2022 Mar;52(2):260-268.
3
Identification of FAM107A as a potential biomarker and therapeutic target for prostate carcinoma.
硫酸酯酶1通过FAK/PI3K/AKT/mTOR信号通路调节ARSH,从而调控结直肠癌的恶性进展。
Cancer Cell Int. 2024 Jun 6;24(1):201. doi: 10.1186/s12935-024-03383-5.
4
Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway.Flavokawain C 通过 FAK/PI3K/AKT 信号通路抑制肝癌细胞的增殖和迁移。
J Cancer Res Clin Oncol. 2024 Mar 9;150(3):117. doi: 10.1007/s00432-024-05639-z.
5
Roles and inhibitors of FAK in cancer: current advances and future directions.黏着斑激酶在癌症中的作用及抑制剂:当前进展与未来方向
Front Pharmacol. 2024 Feb 12;15:1274209. doi: 10.3389/fphar.2024.1274209. eCollection 2024.
6
Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer.m6A 修饰在调控癌症中 PI3K/AKT 信号通路中的作用。
J Transl Med. 2023 Nov 1;21(1):774. doi: 10.1186/s12967-023-04651-0.
7
Overexpression of YEATS2 Remodels the Extracellular Matrix to Promote Hepatocellular Carcinoma Progression via the PI3K/AKT Pathway.YEATS2的过表达通过PI3K/AKT途径重塑细胞外基质以促进肝细胞癌进展。
Cancers (Basel). 2023 Mar 20;15(6):1850. doi: 10.3390/cancers15061850.
8
The molecular phenotype of kisspeptin neurons in the medial amygdala of female mice.雌性小鼠杏仁核内侧吻肽神经元的分子表型。
Front Endocrinol (Lausanne). 2023 Feb 10;14:1093592. doi: 10.3389/fendo.2023.1093592. eCollection 2023.
鉴定FAM107A作为前列腺癌的潜在生物标志物和治疗靶点。
Am J Transl Res. 2021 Sep 15;13(9):10163-10177. eCollection 2021.
4
Promoter Hypermethylation of Tumor Suppressor Genes Located on Short Arm of the Chromosome 3 as Potential Biomarker for the Diagnosis of Nasopharyngeal Carcinoma.位于3号染色体短臂上的肿瘤抑制基因启动子高甲基化作为鼻咽癌诊断的潜在生物标志物
Diagnostics (Basel). 2021 Aug 3;11(8):1404. doi: 10.3390/diagnostics11081404.
5
The Differential Antitumor Activity of 5-Aza-2'-deoxycytidine in Prostate Cancer DU145, 22RV1, and LNCaP Cells.5-氮杂-2'-脱氧胞苷在前列腺癌DU145、22RV1和LNCaP细胞中的差异抗肿瘤活性
J Cancer. 2021 Jul 25;12(18):5593-5604. doi: 10.7150/jca.56709. eCollection 2021.
6
Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function.通过恢复肿瘤抑制基因功能克服抗癌药物耐药性。
Drug Resist Updat. 2021 Jul;57:100770. doi: 10.1016/j.drup.2021.100770. Epub 2021 Jun 18.
7
Loss of family with sequence similarity 107, member A (FAM107A) induces browning in 3T3-L1 adipocytes.家族性序列相似性 107 成员 A(FAM107A)缺失可诱导 3T3-L1 脂肪细胞的棕色化。
Arch Biochem Biophys. 2021 Jun 15;704:108885. doi: 10.1016/j.abb.2021.108885. Epub 2021 Apr 18.
8
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
9
New Insights on Fak and Fak Inhibitors.法卡和法卡抑制剂的新见解。
Curr Med Chem. 2021;28(17):3318-3338. doi: 10.2174/0929867327666201103162239.
10
DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation.DRR1 通过调节 AKT 的激活促进胶质母细胞瘤细胞的侵袭和上皮-间充质转化。
Cancer Lett. 2018 Jun 1;423:86-94. doi: 10.1016/j.canlet.2018.03.015. Epub 2018 Mar 13.